Nearly 500,000 Australian Men to Live With Prostate Cancer by 2050

PCFA

Nearly half a million Australian men projected to be living with or beyond prostate cancer by 2050

Nearly half a million Australian men are likely to be living with or beyond prostate cancer by 2050, according to projections in a major national study, placing growing pressure on health services and highlighting the urgent need for greater investment in research and support.

The study, published in The Lancet Regional Health - Western Pacific, projects that around 469,000 Australian men will be living with or beyond a prostate cancer diagnosis by 2050, an increase of more than 51 per cent from an estimated 309,000 men in 2025.

Around 29,000 Australian men are currently diagnosed with prostate cancer each year. The number of men diagnosed within the previous five years, who are most likely to need monitoring or ongoing care, is projected to rise from about 101,000 to 137,000 by 2050.

Prostate Cancer Foundation of Australia (PCFA) CEO Anne Savage said that despite significant progress in prostate cancer survival, the fight against the disease was far from over.

"These projections are a strong reminder that we cannot afford to slow down investment in research and specialist care," Ms Savage said.

"Our priority must be ensuring that every man has access to early diagnosis, world-class treatment and the specialist support needed to navigate life during and beyond cancer.

"Thousands of Australian men live with ongoing physical and mental challenges after their treatment and need specialist nursing care and psychosocial care to manage them.

"More men living longer means more men living with the side effects of treatment, increasing the urgency of ongoing clinical and nurse-led research to deliver treatments that are kinder as well as more effective."

PCFA is calling on Australians to support its annual Giving Day, with every donation matched by PCFA corporate partners between now and midnight on 19 November.

"With your help, we can continue to develop more effective forms of early detection and better treatments to reduce side effects, preserve quality of life and extend survival time," she said.

The growing prevalence of prostate cancer is also having a significant impact on Australia's health system. Recent data from the Australian Institute of Health and Welfare shows that prostate cancer accounted for $1.8 billion in health expenditure in 2024-25, more than any other cancer affecting Australian men.

"The rising number of Australian men being diagnosed with, and living beyond, prostate cancer will continue to place increasing pressure on our health system unless we invest in better ways to detect, treat and manage the disease," Ms Savage said.

"Research remains our most powerful tool for reducing the impact of prostate cancer. Every advancement starts with research, and Giving Day gives Australians a practical way to drive that progress forward.

"Thanks to our generous corporate partners, every donation made through Giving Day will be matched, helping to fund double the research for Australian men and their families."

Read this story as it was covered in today's The Canberra Times, featuring PCFA ambassador Paul Bain (pictured above): The race to find new cancer treatments

Australians can support PCFA's Giving Day and have their donation matched by visiting www.pcfagivingday.org.au.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.